Modeling human disease in yeast: recreating the PI3K-PTEN-Akt signaling pathway in Saccharomyces cerevisiae.
Disease Susceptibility
Genes, Tumor Suppressor
Genetic Engineering
Humans
Models, Biological
Oncogenes
PTEN Phosphohydrolase
/ metabolism
Phosphatidylinositol 3-Kinase
/ metabolism
Proto-Oncogene Proteins c-akt
/ metabolism
Saccharomyces cerevisiae
/ metabolism
Saccharomycetales
/ metabolism
Second Messenger Systems
Signal Transduction
/ drug effects
Cancer
Humanized yeast models
PI3K
Saccharomyces cerevisiae
Signaling
Journal
International microbiology : the official journal of the Spanish Society for Microbiology
ISSN: 1618-1905
Titre abrégé: Int Microbiol
Pays: Switzerland
ID NLM: 9816585
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
05
03
2019
accepted:
23
04
2019
revised:
08
04
2019
pubmed:
21
6
2019
medline:
8
10
2020
entrez:
21
6
2019
Statut:
ppublish
Résumé
The yeast Saccharomyces cerevisiae is a model organism that has been thoroughly exploited to understand the universal mechanisms that govern signaling pathways. Due to its ease of manipulation, humanized yeast models that successfully reproduce the function of human genes permit the development of highly efficient genetic approaches for molecular studies. Of special interest are those pathways related to human disease that are conserved from yeast to mammals. However, it is also possible to engineer yeast cells to implement functions that are naturally absent in fungi. Along the years, we have reconstructed several aspects of the mammalian phosphatidylinositol 3-kinase (PI3K) pathway in S. cerevisiae. Here, we briefly review the use of S. cerevisiae as a tool to study human oncogenes and tumor suppressors, and we present an overview of the models applied to the study of the PI3K oncoproteins, the tumor suppressor PTEN, and the Akt protein kinase. We discuss the application of these models to study the basic functional properties of these signaling proteins, the functional assessment of their clinically relevant variants, and the design of feasible platforms for drug discovery.
Identifiants
pubmed: 31218536
doi: 10.1007/s10123-019-00082-4
pii: 10.1007/s10123-019-00082-4
doi:
Substances chimiques
Phosphatidylinositol 3-Kinase
EC 2.7.1.137
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
PTEN Phosphohydrolase
EC 3.1.3.67
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
75-87Subventions
Organisme : Ministerio de Economía y Competitividad
ID : BIO2016-75030-P
Organisme : Ministerio de Economía y Competitividad
ID : SAF2016-79847-R
Organisme : Comunidad de Madrid
ID : S2017/BMD-3691-InGEMICS-CM